Literature DB >> 2458153

Establishment and characterization of an amylase-producing human myeloma cell line.

H Matsuzaki1, H Hata, M Takeya, K Takatsuki.   

Abstract

Two stable lines of IgA lambda-producing plasma cells (KHM-1A and KHM-1B) that were free of the Epstein-Barr virus were established from a patient with multiple myeloma complicated by hyperamylasemia. Surface marker studies of the two cell lines showed that the cells had no surface immunoglobulins but were positive for cytoplasmic immunoglobulins (IgA lambda) and for HLA-DR and PCA-1. Secretion of IgA monoclonal immunoglobulin by the two lines was detected by a plaque-forming cell assay and by an enzyme-linked immunosorbent assay of culture media. KHM-1B cells also secreted alpha-amylase, but no such activity was detected in the culture-conditioned supernatant fluid of KHM-1A.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458153

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Amylase-producing multiple myeloma. Cytochemical, immunohistochemical and immunoelectron microscopic studies.

Authors:  M Takeya; H Matsuzaki; H Hata; K Takatsuki; K Takahashi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.

Authors:  H Hata; H Matsuzaki; F Matsuno; T Sonoki; S Takemoto; N Kuribayashi; A Nagasaki; K Takatsuki
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

3.  Amylase mRNA transcripts in normal tissues and neoplasms: the implication of different expressions of amylase isogenes.

Authors:  K Seyama; T Nukiwa; K Takahashi; H Takahashi; S Kira
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration.

Authors:  N Kuribayashi; H Hata; H Matsuzaki; M Yoshida; T Sonoki; A Nagasaki; T Kimura; N Harada; K Takatsuki
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

5.  Establishment of five human myeloma cell lines.

Authors:  M Namba; T Ohtsuki; M Mori; A Togawa; H Wada; T Sugihara; Y Yawata; T Kimoto
Journal:  In Vitro Cell Dev Biol       Date:  1989-08

6.  Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells.

Authors:  Fumihiko Kawamura; Makoto Inaki; Atsushi Katafuchi; Yu Abe; Naohiro Tsuyama; Yumiko Kurosu; Aki Yanagi; Mitsunori Higuchi; Satoshi Muto; Takumi Yamaura; Hiroyuki Suzuki; Hideyoshi Noji; Shinichi Suzuki; Mitsuaki A Yoshida; Megumi Sasatani; Kenji Kamiya; Masafumi Onodera; Akira Sakai
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

7.  Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.

Authors:  Yusuke Azami; Naohiro Tsuyama; Yu Abe; Misaki Sugai-Takahashi; Ken-Ichi Kudo; Akinobu Ota; Karnan Sivasundaram; Moe Muramatsu; Tomonari Shigemura; Megumi Sasatani; Yuko Hashimoto; Shigehira Saji; Kenji Kamiya; Ichiro Hanamura; Takayuki Ikezoe; Masafumi Onodera; Akira Sakai
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.